BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1134191)

  • 1. Isolated rat hepatocytes as a model to study drug metabolism: dose-dependent metabolism of diphenylhydantoin.
    Inaba T; Umeda T; Mahon WA; Ho J; Jeejeebhoy KN
    Life Sci; 1975 Apr; 16(8):1227-32. PubMed ID: 1134191
    [No Abstract]   [Full Text] [Related]  

  • 2. Diphenylhydantoin metabolism by rat liver microsomes and some of the effects of drug or chemical pretreatment on diphenylhydantoin metabolism by rat liver microsomal preparations.
    Kutt H; Fouts JR
    J Pharmacol Exp Ther; 1971 Jan; 176(1):11-26. PubMed ID: 5569630
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolism of phenytoin by isolated hepatocytes and hepatic microsomes from male rats.
    Tsuru M; Erickson RR; Holtzman JL
    J Pharmacol Exp Ther; 1982 Sep; 222(3):658-61. PubMed ID: 7108769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of d-propoxyphene and diphenylhydantoin in rat liver microsomal preparation.
    Verebey K
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):21-9. PubMed ID: 663405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of phenobarbital on plasma diphenylhydantoin level and metabolism in man and in rat liver microsomes.
    Kutt H; Haynes J; Verebely K; McDowell F
    Neurology; 1969 Jun; 19(6):611-6. PubMed ID: 5814306
    [No Abstract]   [Full Text] [Related]  

  • 6. Diphenylhydantoin metabolism. A prospective review.
    Glazko AJ
    Drug Metab Dispos; 1973; 1(5):711-4. PubMed ID: 4149711
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of dose-dependent metabolism of 5,5-diphenyl-hydantoin in the rat using new methodology for isolation and quantitation of metabolites in vivo and in vitro.
    Gerber N; Weller WL; Lynn R; Rangno RE; Sweetman BJ; Bush MT
    J Pharmacol Exp Ther; 1971 Sep; 178(3):567-79. PubMed ID: 5571905
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on 5,5-diphenylhydantoin irreversible binding to rat liver microsomal proteins.
    Pantarotto C; Arboix M; Sezzano P; Abbruzzi R
    Biochem Pharmacol; 1982 Apr; 31(8):1501-7. PubMed ID: 7092941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model describing the disposition of phenytoin in isolated rat hepatocytes.
    Morais JA; Wagner JG
    Biopharm Drug Dispos; 1984; 5(4):357-76. PubMed ID: 6525443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of diphenylhydantoin by rat liver microsomes. I. characteristics of the reaction.
    Kutt H; Verebely K
    Biochem Pharmacol; 1970 Mar; 19(3):675-86. PubMed ID: 4396252
    [No Abstract]   [Full Text] [Related]  

  • 11. Measurement of effect of interferon on metabolism of diphenylhydantoin.
    Sonnenfeld G; Nerland DE
    Methods Enzymol; 1986; 119():715-8. PubMed ID: 2429163
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxylation of 5,5-diphenylhydantoin (phenytoin) by dog liver microsomes.
    Butler TC; Dudley KH; Mitchell GN; Johnson D
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):4-9. PubMed ID: 21639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreases in phenytoin hydroxylation activities catalyzed by liver microsomal cytochrome P450 enzymes in phenytoin-treated rats.
    Yamazaki H; Komatsu T; Takemoto K; Saeki M; Minami Y; Kawaguchi Y; Shimada N; Nakajima M; Yokoi T
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):427-34. PubMed ID: 11259327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake and metabolism of diphenylhydantoin in the isolated perfused rat liver.
    Inaba T; Umeda T; Endrenyi L; Mahon WA; Kalow W
    Biochem Pharmacol; 1978; 27(8):1151-8. PubMed ID: 697916
    [No Abstract]   [Full Text] [Related]  

  • 15. Felbamate in vitro metabolism by rat liver microsomes.
    Adusumalli VE; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1991; 19(6):1135-8. PubMed ID: 1687021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro hydroxylation of diphenylhydantoin and its inhibition by other commonly used anticonvulsant drugs.
    Patsalos PN; Lascelles PT
    Biochem Pharmacol; 1977 Oct; 26(20):1929-33. PubMed ID: 911347
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of diphenylhydantoin metabolism in rats and in rat liver microsomes by antitubercular drugs.
    Kutt H; Verebely K; McDowell F
    Neurology; 1968 Jul; 18(7):706-10. PubMed ID: 5691599
    [No Abstract]   [Full Text] [Related]  

  • 18. Stereoselective inhibition of diphenylhydantoin metabolism by p-hydroxyphenyl-phenylhydantoin enantiomers in rats.
    Huang JD; Hsieh CY
    Chirality; 1991; 3(6):454-9. PubMed ID: 1812955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postnatal development of phenytoin metabolic activity in rat liver microsomes.
    Blake DA; Cohen F; Miyasaki BC
    Drug Metab Dispos; 1978; 6(3):240-5. PubMed ID: 26543
    [No Abstract]   [Full Text] [Related]  

  • 20. Study of the stereoselectivity of the para-hydroxylation of diphenylhydantoin by the rat liver microsomal cytochrome P-450-dependent enzymes [proceedings].
    Cavalier R; Toussaint A; Cumps J
    Arch Int Physiol Biochim; 1978 May; 86(2):411-3. PubMed ID: 81000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.